Back to results
US 2015/0031765 A1Published application
Treatment of cognitive impairment
OwnerMaurice Robert CROSS, Mikael S. THOMSEN +1inventors
InventorsMaurice Robert CROSS, Mikael S. THOMSEN, Jenny HAGGLOF
Life of this patent
Estimating the term…
Abstract
The present invention relates to a compound with the core structure of formula (I), or pharmaceutically acceptable salts or esters, solvates, or prodrugs thereof, for use in the treatment of cognitive impairment in a mammal. The compound is preferably isosteviol or steviol, or pharmaceutically acceptable salts or esters, solvates, or prodrugs thereof.
Claims18
A pharmaceutically active compound comprising the core structure of formula (I)
- or a pharmaceutically acceptable salt, ester, solvate, or prodrug of said active compound,
- with the proviso that the active compound is not stevioside, steviolbioside, rebaudioside A, rebaudioside B or rebaudioside C.
Dependencies are inferred from the claim text.